Deprescribing: The Highest-Impact Clinical Service Pharmacists Can Deliver
🔓 Free Teaser Reference Card Geriatrics
Aug 2, 2026 · Published in: PharmD Signal Reference Card
Evidence-based frameworks for pharmacist-led deprescribing of PPIs, benzodiazepines, opioids, anticholinergics, and antihyperglycemics.
Consensus measurement framework for community pharmacy medication review outcomes
Analysis Geriatrics / Geriatric Pharmacy Confirmatory Grade: Low
Vogt CJ, Eickhoff C, Foulon V, et al.
Sep 16, 2026 · Published in: International Journal of Clinical Pharmacy
Harmonizing outcome measures boosts medication review quality for older adults.
Scoping Review Maps Global Patterns of Drug Over- and Underprescribing
Analysis Geriatrics / Geriatric Pharmacy Confirmatory Grade: Very Low
Bindel LJ, Seifert R
Sep 15, 2026 · Published in: Naunyn-Schmiedeberg's Archives of Pharmacology
Inappropriate drug prescribing spans cardiovascular to pulmonary diseases.
Pharmacy technician home visits feasible for housebound polypharmacy patients
Analysis Geriatrics / Geriatric Pharmacy Hypothesis-generating Grade: Very Low
Ramos T, Cochrane L, Verma A, et al.
Sep 12, 2026 · Published in: International Journal of Clinical Pharmacy
Home pharmacy visits reduce falls and improve life quality in elderly.
Pharmacist-Led Deprescribing Halves Inappropriate Medications in Older Cancer Patients
Analysis Geriatrics / Geriatric Pharmacy Hypothesis-generating Grade: Low
Maleki S, Foo J, Zamani M, et al.
Sep 12, 2026 · Published in: Journal of Geriatric Oncology
Deprescribing cuts inappropriate medication use in cancer care for older adults.
Twenty-four high-priority prescribing cascades prioritized in older adults
Analysis Geriatrics / Geriatric Pharmacy Confirmatory Grade: Moderate
Rochon PA, Austin PC, Gurwitz JH, et al.
Sep 11, 2026 · Published in: BMJ (Clinical Research Ed.)
Prioritised prescribing cascades highlight risks in older adults.
New Canadian Guideline Frames Statin Deprescribing for Adults 65 and Older
Guideline Geriatrics / Geriatric Pharmacy Practice-changing Grade: Very Low
Thompson W, Barry AR, McCarthy LM, et al.
Sep 11, 2026 · Published in: Canadian Family Physician Medecin De Famille Canadien
New guideline supports personalized statin deprescribing for older adults.
DOAC Renal Signals Differ: Dabigatran and Edoxaban Lead
Analysis Geriatrics / Geriatric Pharmacy Hypothesis-generating Grade: Very Low
Chen S, Shi C, Li X, et al.
Sep 10, 2026 · Published in: Renal Failure
DTIs show higher kidney injury risk than FXaIs in DOAC users.
LAIAs help intellectual disability patients with SMI, not off-label behavior
Analysis Geriatrics / Geriatric Pharmacy Hypothesis-generating Grade: Low
Leung SM, Lee KJ, Wei Y, et al.
Sep 8, 2026 · Published in: BMJ Mental Health
LAIAs show promise for PWID with schizophrenia or bipolar disorder, but caution is needed for others.
Risks of Psychotropic Use in Alzheimer's Disease
Guideline Geriatrics / Geriatric Pharmacy
Gou KJ, Chen Y, Sheng Z, et al.
Sep 8, 2026 · Published in: Current Alzheimer Research
Psychotropic polypharmacy poses significant risks in Alzheimer's disease.
Non-Psychotropic Polypharmacy Rises With Age in Psychiatric Inpatients
Analysis Geriatrics / Geriatric Pharmacy Hypothesis-generating Grade: Low
Uju Y, Kanzaki T, Hosoi R, et al.
Sep 1, 2026 · Published in: Medicine
Non-psychotropic polypharmacy in psychiatric patients rises with age and comorbidities.
One in Four Older Acute Patients Has Actionable Drug-Gene Interaction
Analysis Geriatrics / Geriatric Pharmacy Hypothesis-generating Grade: Low
Christensen LWS, Boas AK, Clausen E, et al.
Aug 29, 2026 · Published in: British Journal of Clinical Pharmacology
PGx testing identifies clinically relevant drug-gene interactions in over 26% of older adults in acute care.
Anticholinergic Exposure Reaches 74% in Community-Dwelling Elders, Scales Disagree
Analysis Geriatrics / Geriatric Pharmacy Confirmatory Grade: Moderate
Rodríguez-Salas FB, Merchán-Cruz MA, Ocaña-Riola R, et al.
Aug 15, 2026 · Published in: Frontiers in Pharmacology
Anticholinergic burden is prevalent but tricky to measure in elders.
Co-designing a pharmacist-led emergency department transition-of-care blueprint
Analysis Geriatrics / Geriatric Pharmacy Hypothesis-generating Grade: Very Low
Alhmoud E, Barazi R, Thomas B, et al.
Aug 14, 2026 · Published in: International Journal of Clinical Pharmacy
Pharmacist-led transitions can reduce medication harm post-ED discharge.
Korea's Hospital Polypharmacy Program Cuts 90-Day Readmissions in Elders
Analysis Geriatrics / Geriatric Pharmacy Confirmatory Grade: Moderate
Jang S, Lim J, Moon A, et al.
Aug 8, 2026 · Published in: Drugs & Aging
Polypharmacy management slashes readmission rates and costs for older adults.